APRICUS BIOSCIENCES, INC. 4
4 · APRICUS BIOSCIENCES, INC. · Filed Jun 5, 2017
Insider Transaction Report
Form 4
Morton Neil
SVP, Chief Business Officer
Transactions
- Award
Common Stock
2017-06-01+75,000→ 162,118 total
Footnotes (2)
- [F1]Award of 75,000 Restricted Stock Units ("RSUs") under the Issuer's Amended and Restated 2012 Stock Long Term Incentive Plan with half of the underlying shares vesting in the first open trading window following the Issuer's submission of Vitaros in the United States to the Food and Drug Administration ("FDA") and the other half of the underlying shares vesting in the first open trading window following the Issuer's receipt of marketing approval of Vitaros in the United States by the FDA, subject to the Reporting Person's continued employment or service to the Issuer through such date and subject to accelerated vesting upon a change in control of the Issuer.
- [F2]Not applicable.